Next Article in Journal
Curcumin Alleviates HMGB1-Mediated Inflammation Through the Signaling Pathway of TLR2-NF-κB in Bovine Ovarian Granulosa Cells
Previous Article in Journal
The Metabolic Screening in Wounded Scales of Hippeastrum × hybridum Hort. Bulbs
 
 
Article
Peer-Review Record

Lactobacillus fermentum Inhibits the Development of Colitis by Regulating the Intestinal Microbiota and Metabolites to Enhance the Intestinal Barrier and Decrease Inflammatory Responses

Int. J. Mol. Sci. 2025, 26(18), 9181; https://doi.org/10.3390/ijms26189181
by Xiaoyan You 1, Pengcheng Shi 1, Wenjing Liu 2, Mengyi Zheng 2, Lixia Jin 2,* and Wei Liu 3,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2025, 26(18), 9181; https://doi.org/10.3390/ijms26189181
Submission received: 15 August 2025 / Revised: 15 September 2025 / Accepted: 17 September 2025 / Published: 19 September 2025

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Dear Authors,

I've read you paper with great interest. Please find my comments on the pdf file. I look forward to your revised work.

Best,

Comments for author File: Comments.pdf

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

The article examines the protective effects of Lactobacillus fermentum in a model of ulcerative colitis. The study is well designed, and the results are generally well presented and discussed. However, I would like to suggest several points for improvement:

  1. In the introduction, please provide a rationale for selecting fermentum S1 for this study. In addition, give a brief summary of the previously reported effects of this strain.
  2. Define the abbreviation DAI when it is first mentioned (line 92).
  3. Indicate the number of animals included in each analysis within the corresponding figure legends.
  4. Provide more methodological details regarding ICH staining and quantification. Specifically, clarify which background color was used during staining.
  5. Line 184: there is an error in the text. Figure 4(E) does not present butyric acid; please correct this.
  6. Supply higher-resolution images for Figure 6, as the text is currently unreadable.
  7. Add references and further explanation for the following statements: “Saroclazine A can play an anti-inflammatory role” (line 414) and “Marvinbryantia can have a positive effect on N-(1-deoxysructosyl)-isoleucyl-aspartate, which has significant relevance. Therefore, it can be hypothesized that N-(1-deoxyfructos-1-yl)-isoleucyl-aspartate is involved in exacerbating UC” (lines 419–420). Additionally, ensure that Marvinbryantia is written in italics.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 1 Report

Comments and Suggestions for Authors

Dear Authors,

I believe that the point by point responses you uploaded are for the other reviewer and not mine. However, I went through the manuscript and found most of the changes and improvements I commented upon. My last request would be regarding the figures as some are still unreadable, for example fig 7 has really small fonts. (also an error = unchageD, the d is missing). You can use the whole page of the manuscript since MDPI does not have any limitations for images, this included the left side of the page (the alignment is restricted only for text not for tables and images). This together with the high DPIs will ensure a better readability of your figures)

Best,

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop